Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 07, 2024 |
| PDB ID | UniProt ID | Title ▼ | Descriptor |
|---|---|---|---|
| 6XI2 | Q8NAT1 | Apo form of POMGNT2 | Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (E.C.2.4.1.312), ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA, ALA-GLY-ALA-GLY-ALA-ALA-ALA-ALA-ALA-ALA |
| 6XI2 | 6XI2 | Apo form of POMGNT2 | Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (E.C.2.4.1.312), ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA, ALA-GLY-ALA-GLY-ALA-ALA-ALA-ALA-ALA-ALA |
| 3C6Q | Q9WXW9 | Apo and ligand-bound form of a thermophilic glucose/xylose binding protein | |
| 6OAZ | P06858 | Apo Structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells | |
| 6OAZ | Q8IV16 | Apo Structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells | |
| 6OAU | P06858 | Apo Structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in GnTI-deficient HEK293-F cells | |
| 6OAU | Q8IV16 | Apo Structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in GnTI-deficient HEK293-F cells | |
| 8ON8 | 8ON8 | Apo Malacoceros FaNaC1 in lipid nanodiscs | |
| 4DBM | Q8WSF8 | Aplysia californica-AChBP in complex with triazole 18 | |
| 8QTL | Q8WSF8 | Aplysia californica acetylcholine-binding protein in complex with Spiroimine (-)-4 S | |
| 8Q1M | Q8WSF8 | Aplysia californica acetylcholine-binding protein in complex with Spiroimine (+)-4 R | |
| 7YVB | 7YVB | Aplysia californica FaNaC in ligand bound state | |
| 7YVB | Q4TZI8 | Aplysia californica FaNaC in ligand bound state | |
| 7YVB | 7YVB | Aplysia californica FaNaC in ligand bound state | |
| 7YVB | Q4TZI8 | Aplysia californica FaNaC in ligand bound state | |
| 7YVC | Q4TZI8 | Aplysia californica FaNaC in apo state | |
| 7YVC | 7YVC | Aplysia californica FaNaC in apo state | |
| 7YVC | Q4TZI8 | Aplysia californica FaNaC in apo state | |
| 7YVC | 7YVC | Aplysia californica FaNaC in apo state | |
| 6T9R | Q8WSF8 | Aplysia californica AChBP in complex with a cytisine derivative | |
| 6QQO | Q8WSF8 | Aplysia californica AChBP in complex with 2-Fluoro-(carbamoylpyridinyl)deschloroepibatidine analogue (3) | |
| 6QQP | Q8WSF8 | Aplysia californica AChBP in complex with 2-Fluoro-(carbamoylpyridinyl)deschloroepibatidine analogue (2) | |
| 6QKK | Q8WSF8 | Aplysia californica AChBP in complex with 2-Fluoro-(carbamoylpyridinyl)deschloroepibatidine analogue (1) | |
| 7T9B | 7T9B | ApexGT5 in complex with GT5-d42.16 and RM20A3 Fabs | |
| 7T9B | Q2N0S6 | ApexGT5 in complex with GT5-d42.16 and RM20A3 Fabs | |
| 7T9A | 7T9A | ApexGT2 in complex with GT2-d42.16 and RM20A3 Fabs | |
| 7T9A | Q2N0S8 | ApexGT2 in complex with GT2-d42.16 and RM20A3 Fabs | |
| 1VA5 | P0A4V4 | Antigen 85C with octylthioglucoside in active site | |
| 8FR6 | Q2N0S7 | Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 8FR6 | Q2N0S6 | Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 8FR6 | 8FR6 | Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 4XNQ | 4XNQ | Antibody hemagglutinin Complexes | |
| 4XNQ | H8PCX0 | Antibody hemagglutinin Complexes | |
| 4XRC | 4XRC | Antibody hemagglutinin Complexes | |
| 4XRC | Q6Q9G9 | Antibody hemagglutinin Complexes | |
| 4XNM | 4XNM | Antibody Influenza H5 Complex | |
| 4XNM | H8PCX0 | Antibody Influenza H5 Complex | |
| 3VG0 | 3VG0 | Antibody Fab fragment | |
| 7SJ0 | P0DTC2 | Antibody A7V3 bound to N-terminal domain of the spike | |
| 7SJ0 | 7SJ0 | Antibody A7V3 bound to N-terminal domain of the spike | |
| 3OAU | 3OAU | Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Non-Domain-Exchanged Forms, but only binds the HIV-1 Glycan Shield if Domain-Exchanged | Fab 2G12, heavy chain, Fab 2G12, light chain |
| 7M7W | 7M7W | Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape | |
| 7M7W | P0DTC2 | Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape | |
| 7KQG | E1TVD5 | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQG | 7KQG | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQH | A0A4P8YRB6 | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQH | 7KQH | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQI | 7KQI | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQI | A4D5Q0 | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 6S2I | 6S2I | Anti-tumor antibody 14F7-derived scFv in complex with NeuGc Gm3 |
